XM does not provide services to residents of the United States of America.

Deals of the day-Mergers and acquisitions



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Deals of the day-Mergers and acquisitions</title></head><body>

Adds Thoma Bravo, Recursion Pharmaceuticals, Bellway

Aug 8 (Reuters) -The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Thursday:


** Thoma Bravo is preparing to explore options including a potential sale of ABC Fitness Solutions that could value the software provider for health clubs and gyms at about $3 billion including debt, according to people familiar with the matter. nL8N3JU3TU

** Recursion Pharmaceuticals RXRX.O, a biotech firm which uses artificial intelligence to discover new drug candidates, has agreed to buy smaller rival Exscientia EXAI.O for $688 million in an all-stock deal, according to a statement seen by Reuters. nL1N3JV0C5

** The UK Takeover Panel has extended the deadline for the 720 million pound ($913.7 million) all-share takeover proposal by homebuilder Bellway BWY.L for its FTSE midcap peer Crest Nicholson CRST.L to Aug. 20, the companies said. nL4N3JV0Y6


** Swedish financial investor EQT EQTAB.ST said on Wednesday it will acquire a majority stake in Swiss cybersecurity and data protection company Acronis. nL1N3JU0FD


** U.S. private equity firm KKR & Co KKR.N will launch a tender offer for Japan's Fuji Soft 9749.T, the companies said, in a 558.4 billion yen ($3.8 billion) deal to take the software developer private. nL4N3JV0VK


** Savannah Energy SAVES.L said on Wednesday it has terminated the planned $1.25 billion purchase of Malaysia's state energy firm Petronas' oil and gas business in South Sudan, as the parties could not close the deal on the originally envisaged terms. nL4N3JU2AE


** UK's competition regulator said its phase 1 review into homebuilder Barratt's BDEV.L 2.52 billion pound ($3.21 billion) all-stock deal to buy smaller rival Redrow RDW.L had raised concerns in the local area around a Barratt development. nL4N3JV0NP


** Australia's Pacific Smiles PSQ.AX said its shareholders have voted against National Dental Care's (NDC) A$327.1 million ($214.5 million) takeover offer. nL4N3JV0FU


** Walt Disney DIS.N said on Wednesday it may have to pay up to $5 billion more to buy Comcast's CMCSA.O minority stake in Hulu, if an appraiser were to agree with Comcast's assessment that the stake should be valued at more than $40 billion. nL4N3JU2DM


** Equity Residential EQR.N has agreed to acquire 11 apartment properties located in its expansion markets such as Atlanta and Denver from Blackstone BX.N for about $964 million, the companies said on Wednesday. nL4N3JU1YG


(Compiled by Rajarshi Roy and Priyanka.G in Bengaluru)

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.